SINTX TECHNOLOGIES INC (SINT) Stock Price, Forecast & Analysis
NASDAQ:SINT • US8293927039
SINT Key Statistics, Chart & Performance
The current stock price of SINT is 2.94 USD. In the past month the price decreased by -16.24%. In the past year, price decreased by -11.18%.
SINT Technical Analysis
SINT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SINT. While SINT seems to be doing ok healthwise, there are quite some concerns on its profitability.
SINT Financial Highlights
Over the last trailing twelve months SINT reported a non-GAAP Earnings per Share(EPS) of -6.8. The EPS increased by 92.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -145.75% | ||
| ROE | -407.15% | ||
| Debt/Equity | 0 |
SINT Forecast & Estimates
7 analysts have analysed SINT and the average price target is 16.32 USD. This implies a price increase of 455.1% is expected in the next year compared to the current price of 2.94.
For the next year, analysts expect an EPS growth of 62.03% and a revenue growth -67.16% for SINT
SINT Ownership
SINT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 20.08 | 200.474B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.15 | 174.759B | ||
| SYK | STRYKER CORP | 25.44 | 147.128B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.23 | 110.292B | ||
| BDX | BECTON DICKINSON AND CO | 11.7 | 52.52B | ||
| IDXX | IDEXX LABORATORIES INC | 42.06 | 49.757B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.73 | 47.84B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.7 | 38.219B | ||
| RMD | RESMED INC | 21.24 | 37.992B | ||
| DXCM | DEXCOM INC | 29.02 | 28.573B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SINT
Company Profile
SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 20 full-time employees. The company went IPO on 2014-02-11. The company is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. The company has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. The company manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Company Info
SINTX TECHNOLOGIES INC
1885 West 2100 Street
Salt Lake City UTAH 84119 US
CEO: B. Sonny Bal
Employees: 20
Phone: 18018393516
SINTX TECHNOLOGIES INC / SINT FAQ
Can you describe the business of SINTX TECHNOLOGIES INC?
SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 20 full-time employees. The company went IPO on 2014-02-11. The company is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. The company has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. The company manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
What is the stock price of SINTX TECHNOLOGIES INC today?
The current stock price of SINT is 2.94 USD. The price decreased by -2.97% in the last trading session.
Does SINT stock pay dividends?
SINT does not pay a dividend.
What is the ChartMill rating of SINTX TECHNOLOGIES INC stock?
SINT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of SINT stock?
SINTX TECHNOLOGIES INC (SINT) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the market capitalization of SINT stock?
SINTX TECHNOLOGIES INC (SINT) has a market capitalization of 11.32M USD. This makes SINT a Nano Cap stock.